ArticleBMC veterinary research2026
Mycobacterium bovis induces cellular oxidative stress via the host protein SH3PXD2B.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Mycobacterium bovis (M. bovis) is a major pathogen that causes zoonotic tuberculosis. It is transmitted via aerosols, colonizes the lungs of the host and causes oxidative stress in macrophages, resulting in tissue damage. The mechanisms underlying the oxidative damage to cells induced by this infection have not yet been fully elucidated. This study investigated the effects of SH3PXD2B on the production of reactive oxygen species (ROS) and antioxidant mechanisms during M. bovis infection. The results showed that SH3PXD2B expression was significantly upregulated after M. bovis infection, and promoted the production of cellular NOX-dependent ROS and the lipid peroxidation marker MDA. Additionally, overexpression of SH3PXD2B inhibited the Nrf2 antioxidant pathway and reduced the activities of antioxidant enzymes such as CAT, SOD, and GPx. Conversely, knockdown of SH3PXD2B exerted the opposite effect and improved cell viability. In summary, SH3PXD2B orchestrates M. bovis-induced oxidative stress in macrophages through a dual mechanism: amplifying ROS production while simultaneously crippling the host's antioxidant capacity. These findings provide novel mechanistic insights into M. bovis pathogenesis and suggest that SH3PXD2B may be a potential molecular target for future research into disease resistance in cattle and the development of new therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.